Biomarker Testing for Ovarian Cancer: Clinical Utility of Multiplex Assays
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Biomarker Testing for Ovarian Cancer: Clinical Utility of Multiplex Assays
Authors
Keywords
Ovarian Cancer, Positive Predictive Value, Negative Predictive Value, Ovarian Cancer Patient, Pelvic Mass
Journal
Molecular Diagnosis & Therapy
Volume 17, Issue 3, Pages 139-146
Publisher
Springer Nature
Online
2013-04-03
DOI
10.1007/s40291-013-0027-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Results From Four Rounds of Ovarian Cancer Screening in a Randomized Trial
- (2014) Edward Partridge et al. OBSTETRICS AND GYNECOLOGY
- Impact of Screening Test Performance and Cost on Mortality Reduction and Cost-effectiveness of Multimodal Ovarian Cancer Screening
- (2012) C. W. Drescher et al. Cancer Prevention Research
- Subjective assessment by ultrasound is superior to the risk of malignancy index (RMI) or the risk of ovarian malignancy algorithm (ROMA) in discriminating benign from malignant adnexal masses
- (2012) Toon Van Gorp et al. EUROPEAN JOURNAL OF CANCER
- Evaluation of HE4, CA125, risk of ovarian malignancy algorithm (ROMA) and risk of malignancy index (RMI) as diagnostic tools of epithelial ovarian cancer in patients with a pelvic mass
- (2012) Mona Aarenstrup Karlsen et al. GYNECOLOGIC ONCOLOGY
- Comparison of HE4, CA125 and ROMA algorithm in women with a pelvic mass: Correlation with pathological outcome
- (2012) M.T. Sandri et al. GYNECOLOGIC ONCOLOGY
- The use of HE4 in the prediction of ovarian cancer in Asian women with a pelvic mass
- (2012) Karen K.L. Chan et al. GYNECOLOGIC ONCOLOGY
- Potential effect of the risk of ovarian cancer algorithm (ROCA) on the mortality outcome of the Prostate, Lung, Colorectal and Ovarian (PLCO) trial
- (2012) Paul F. Pinsky et al. INTERNATIONAL JOURNAL OF CANCER
- The Utility of Human Epididymal Protein 4, Cancer Antigen 125, and Risk for Malignancy Algorithm in Ovarian Cancer and Endometriosis
- (2012) Sasa Kadija et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Ovarian Cancer Screening
- (2012) Steven J. Skates INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Development of Multiplexed Bead-Based Immunoassays for the Detection of Early Stage Ovarian Cancer Using a Combination of Serum Biomarkers
- (2012) Yong-Wan Kim et al. PLoS One
- Tissue Kim-1 and Urinary Clusterin as Early Indicators of Cisplatin-Induced Acute Kidney Injury in Rats
- (2012) Petra Vinken et al. TOXICOLOGIC PATHOLOGY
- Human epididymis protein 4 offers superior specificity in the differentiation of benign and malignant adnexal masses in premenopausal women
- (2011) Kevin Holcomb et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- HE4 and CA125 as a diagnostic test in ovarian cancer: prospective validation of the Risk of Ovarian Malignancy Algorithm
- (2011) T Van Gorp et al. BRITISH JOURNAL OF CANCER
- Proteomic biomarkers in combination with CA 125 for detection of epithelial ovarian cancer using prediagnostic serum samples from the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial
- (2011) Lee E. Moore et al. CANCER
- Serum Human Epididymis Protein 4 and Risk for Ovarian Malignancy Algorithm as New Diagnostic and Prognostic Tools for Epithelial Ovarian Cancer Management
- (2011) E. Bandiera et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Ovarian Cancer Biomarker Performance in Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial Specimens
- (2011) D. W. Cramer et al. Cancer Prevention Research
- HE4 and epithelial ovarian cancer: Comparison and clinical evaluation of two immunoassays and a combination algorithm
- (2011) Giuseppina Ruggeri et al. CLINICA CHIMICA ACTA
- The ROMA (Risk of Ovarian Malignancy Algorithm) for estimating the risk of epithelial ovarian cancer in women presenting with pelvic mass: is it really useful?
- (2011) Martina Montagnana et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- No benefit from combining HE4 and CA125 as ovarian tumor markers in a clinical setting
- (2011) Francis Jacob et al. GYNECOLOGIC ONCOLOGY
- Human Epididymis Protein 4 (HE4) as a Serum Tumor Biomarker in Patients With Ovarian Carcinoma
- (2011) Xiaohong Chang et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Effect of Screening on Ovarian Cancer Mortality
- (2011) Saundra S. Buys JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Performance of the American College of Obstetricians and Gynecologistsʼ Ovarian Tumor Referral Guidelines With a Multivariate Index Assay
- (2011) Rachel Ware Miller et al. OBSTETRICS AND GYNECOLOGY
- Evaluation of the Diagnostic Accuracy of the Risk of Ovarian Malignancy Algorithm in Women With a Pelvic Mass
- (2011) Richard G. Moore et al. OBSTETRICS AND GYNECOLOGY
- Effectiveness of a Multivariate Index Assay in the Preoperative Assessment of Ovarian Tumors
- (2011) Frederick R. Ueland et al. OBSTETRICS AND GYNECOLOGY
- Comparison of a novel multiple marker assay vs the Risk of Malignancy Index for the prediction of epithelial ovarian cancer in patients with a pelvic mass
- (2010) Richard G. Moore et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- The Road from Discovery to Clinical Diagnostics: Lessons Learned from the First FDA-Cleared In Vitro Diagnostic Multivariate Index Assay of Proteomic Biomarkers
- (2010) Z. Zhang et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Serum biomarker panels for the discrimination of benign from malignant cases in patients with an adnexal mass
- (2010) Brian Nolen et al. GYNECOLOGIC ONCOLOGY
- Phase II biomarker trial of a multimarker diagnostic for ovarian cancer
- (2010) Tracey Edgell et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Development of a Multimarker Assay for Early Detection of Ovarian Cancer
- (2010) Zoya Yurkovetsky et al. JOURNAL OF CLINICAL ONCOLOGY
- ACR Appropriateness Criteria© Ovarian Cancer Screening
- (2010) Douglas L. Brown et al. Ultrasound Quarterly
- Serum HE4 concentration differentiates malignant ovarian tumours from ovarian endometriotic cysts
- (2009) K Huhtinen et al. BRITISH JOURNAL OF CANCER
- Use of a Symptom Index, CA125, and HE4 to predict ovarian cancer
- (2009) M. Robyn Andersen et al. GYNECOLOGIC ONCOLOGY
- Assessing Lead Time of Selected Ovarian Cancer Biomarkers: A Nested Case–Control Study
- (2009) Garnet L. Anderson et al. JNCI-Journal of the National Cancer Institute
- Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)
- (2009) Usha Menon et al. LANCET ONCOLOGY
- Development and Preliminary Evaluation of a Multivariate Index Assay for Ovarian Cancer
- (2009) Suraj D. Amonkar et al. PLoS One
- Diagnostic Markers for Early Detection of Ovarian Cancer
- (2008) I. Visintin et al. CLINICAL CANCER RESEARCH
- A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass
- (2008) Richard G. Moore et al. GYNECOLOGIC ONCOLOGY
- Systematic Evaluation of Candidate Blood Markers for Detecting Ovarian Cancer
- (2008) Chana Palmer et al. PLoS One
- The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass
- (2007) Richard G. Moore et al. GYNECOLOGIC ONCOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now